{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-essential-documents-during-trial-ich-e6-section-8”
},
“headline”: “SOP for Essential Documents During Trial (ICH E6 §8)”,
“description”: “This SOP defines the essential documents required to be filed and maintained during the conduct of a clinical trial, in compliance with ICH E6 §8 and global regulatory requirements, including protocols, approvals, monitoring reports, safety records, IP logs, consent forms, and training documentation.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Essential Documents During Trial (ICH E6 §8)

Purpose

The purpose of this SOP is to define the process for collecting, filing, and maintaining essential documents during the conduct of a clinical trial, as per ICH E6 §8 requirements. These documents collectively enable the evaluation of trial conduct and ensure compliance with GCP, regulatory expectations, and subject protection.

Scope

This SOP applies to sponsors, CROs, investigators, site staff, and QA responsible for maintaining essential documents in the TMF and ISF during the trial. It covers monitoring reports, approvals, informed consent forms, IP accountability logs, correspondence, safety reporting, and other trial-related documentation.

Responsibilities

• Sponsor: Ensures TMF is complete and contemporaneous.
• CRO: Maintains documents delegated by sponsor under oversight.
• Investigator: Maintains ISF and subject-level essential documents.
• CRA: Collects and files monitoring reports, logs, and site-level records.
• QA: Audits TMF and ISF to ensure inspection readiness.
• TMF Administrator: Classifies, indexes, and files documents with quality checks.

Accountability

The Head of Clinical Operations is accountable for overall TMF maintenance during the trial. Investigators are accountable for ISF completeness. QA is accountable for verifying inspection readiness.

Procedure

1. Protocol and Amendments
1.1 File final approved protocol and all subsequent amendments.
1.2 Ensure all amendments are approved by EC/IRB and regulatory authorities.

2. Informed Consent Documentation
2.1 File signed informed consent forms (ICFs) for each subject.
2.2 Ensure contemporaneous version control and language approvals.
2.3 Maintain ICF Filing Log (Annexure-1).

3. Investigator and Site Documentation
3.1 File updated CVs and training certificates of PI and site staff.
3.2 File updated Delegation of Authority Logs.
3.3 File Investigator communication with sponsor/CRO.

4. Monitoring Documentation
4.1 File monitoring visit reports, follow-up letters, and responses.
4.2 Ensure reconciliation between reports and trial activities.
4.3 Maintain Monitoring Report Log (Annexure-2).

5. Investigational Product Documentation
5.1 File IP accountability logs, receipts, dispensing records, and destruction logs.
5.2 File temperature logs and excursion reports.
5.3 Maintain IP Accountability Log (Annexure-3).

6. Safety Documentation
6.1 File SAE reports, SUSAR submissions, and follow-up documentation.
6.2 File DSUR/PSUR submissions and safety committee communications.
6.3 Maintain Safety Reporting Log (Annexure-4).

7. Subject-Level Documentation
7.1 File subject ID logs, screening and enrolment logs.
7.2 File eligibility verification checklists.
7.3 Maintain Subject Tracking Log (Annexure-5).

8. Correspondence and Communication
8.1 File essential correspondence with regulators, ECs/IRBs, CROs, and vendors.
8.2 File minutes of meetings and teleconferences.
8.3 Maintain Correspondence Log (Annexure-6).

9. Training and Qualification
9.1 File training records for staff joining during the trial.
9.2 Maintain GCP training certificates.
9.3 Maintain Training Record Log (Annexure-7).

10. Quality Control
10.1 Perform monthly QC checks on TMF/ISF.
10.2 Document findings in TMF QC Log (Annexure-8).
10.3 Correct discrepancies within 10 working days.

Abbreviations

• SOP: Standard Operating Procedure
• TMF/ISF: Trial Master File / Investigator Site File
• PI: Principal Investigator
• CRA: Clinical Research Associate
• QA: Quality Assurance
• EC/IRB: Ethics Committee / Institutional Review Board
• SAE: Serious Adverse Event
• SUSAR: Suspected Unexpected Serious Adverse Reaction
• DSUR/PSUR: Development Safety Update Report / Periodic Safety Update Report

Documents

1. ICF Filing Log (Annexure-1)
2. Monitoring Report Log (Annexure-2)
3. IP Accountability Log (Annexure-3)
4. Safety Reporting Log (Annexure-4)
5. Subject Tracking Log (Annexure-5)
6. Correspondence Log (Annexure-6)
7. Training Record Log (Annexure-7)
8. TMF QC Log (Annexure-8)

References

• ICH E6(R2/R3) – Essential Documents During Trial
• FDA – TMF Maintenance Guidance
• EMA – TMF and ISF Inspection Guidance
• CDSCO – Essential Documents Filing
• WHO – GCP Essential Documents

Version: 1.0

Approval Section

Annexures

Annexure-1: ICF Filing Log

Annexure-2: Monitoring Report Log

Annexure-3: IP Accountability Log

Annexure-4: Safety Reporting Log

Annexure-5: Subject Tracking Log

Annexure-6: Correspondence Log

Annexure-7: Training Record Log

Annexure-8: TMF QC Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-IP-Reconciliation-and-Accountability-Logs”
},
“headline”: “SOP for IP Reconciliation and Accountability Logs in Clinical Trials”,
“description”: “This SOP outlines standardized procedures for reconciliation and accountability of investigational products (IP) in clinical trials, ensuring accurate documentation and compliance with ICH GCP, FDA, EMA, CDSCO, and WHO standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for IP Reconciliation and Accountability Logs

Purpose

The purpose of this SOP is to define procedures for reconciliation and accountability of investigational products (IP) throughout the lifecycle of a clinical trial. Accurate reconciliation ensures that all IP is tracked from receipt to dispensing, return, or destruction, thus protecting participant safety and ensuring compliance with regulatory guidelines.

Scope

This SOP applies to investigators, pharmacists, study coordinators, sponsors, and CROs involved in IP management. It covers the use of accountability logs, reconciliation at subject and site level, discrepancy management, and documentation in TMF and ISF.

Responsibilities

• Principal Investigator (PI): Responsible for overall accountability of IP at the trial site.
• Pharmacist/Authorized Designee: Maintains accountability logs, performs reconciliation, and reports discrepancies.
• Study Coordinator: Ensures logs are updated, signed, and filed in ISF and TMF.
• Sponsor/CRO: Reviews accountability logs during monitoring visits and trial close-out.
• Quality Assurance Officer: Audits reconciliation records during inspections.

Accountability

The PI is accountable for ensuring that IP reconciliation is performed accurately, timely, and documented appropriately. Sponsors are accountable for verifying reconciliation across all trial sites.

Procedure

1. Receipt and Documentation
Record receipt of IP in the IP Receipt Log.
Verify quantity, lot number, and expiry date against shipment documents.

2. Dispensing Accountability
Record subject ID, quantity dispensed, and batch number in Dispensing Log.
Ensure signatures of dispensing staff and investigator.

3. Returns and Destruction
Record returned and destroyed IP quantities in Accountability Log.
Attach destruction certificate where applicable.

4. Periodic Reconciliation
Perform monthly reconciliation of stock against logs.
Investigate and document discrepancies.
Report unresolved discrepancies to sponsor.

5. Final Reconciliation
Conduct close-out reconciliation with sponsor/CRO.
Ensure final accountability log is signed by PI and filed in ISF and TMF.

6. Archiving
Archive accountability logs for minimum 5 years post-trial or as per national regulations.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• IP: Investigational Product
• CRO: Clinical Research Organization
• ISF: Investigator Site File
• TMF: Trial Master File
• QA: Quality Assurance

Documents

1. IP Accountability Log (Annexure-1)
2. Periodic Reconciliation Report (Annexure-2)
3. Final Reconciliation Certificate (Annexure-3)

References

• ICH E6(R2) – Good Clinical Practice
• US FDA – Clinical Trial Drug Accountability
• EMA Clinical Trial Regulation
• CDSCO Clinical Trial Rules, 2019
• WHO – Guidelines on Pharmaceutical Accountability

Version: 1.0

Approval Section

Annexures

Annexure-1: IP Accountability Log

Annexure-2: Periodic Reconciliation Report

Annexure-3: Final Reconciliation Certificate

Revision History

For more SOPs visit: Pharma SOP